Intervet Inc.

Mark A Mogler

Ruud Philip Antoon Maria Segers

Erin Linn Strait

Pravina Kitikoon

Steven M Callister

Rhonda LaFleur

Zhichang Xu

Erwin Van Den Born

Supraja Puttamreddy

Basav Nagaraj

Jennifer C Dant

The present invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The present invention also provides vaccine against influenza A virus comprising such vectors and/or nucleic acid constructs. The present invention further provides methods of making and using the vaccines alone, or in combination with other protective agents.

Swine influenza a virus vaccine

The present invention relates to vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. To a vaccine, and a kit of parts comprising the replicon particles and the oil adjuvant. Also to methods and uses of making and using the vaccine and the components of the kit.

Vaccination with replicon particles and oil adjuvant

The present invention relates to a method of vaccination. Specifically the invention regards to a prime-boost vaccination regimen for protecting a target animal against infection or disease caused by a virus, wherein the vaccination regimen comprises the administration to said target animal of a vaccine comprising a live attenuated form of said virus, followed by the administration to said target animal of a vaccine comprising an RP encoding one or more antigens from said virus.

Prime-boost vaccination regimen

The present invention provides a vaccine for canine Lyme disease and methods of making and using the vaccine alone, or in combinations with other protective agents.

Canine lyme disease vaccine

Growing community of inventors

Ames, IA, United States of America

Mark A Mogler